These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22574677)

  • 1. The development of medications for alcohol-use disorders targeting the GABAB receptor system.
    Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
    Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G
    Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence.
    Agabio R; Colombo G
    Front Neurosci; 2014; 8():140. PubMed ID: 24936171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder.
    Colombo G
    Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the GABA(B) receptor in alcohol-seeking and drinking behavior.
    Maccioni P; Colombo G
    Alcohol; 2009 Nov; 43(7):555-8. PubMed ID: 19913200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
    Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA
    Holtyn AF; Weerts EM
    Curr Top Behav Neurosci; 2022; 52():157-194. PubMed ID: 32808090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen.
    Maccioni P; Vargiolu D; Thomas AW; Malherbe P; Mugnaini C; Corelli F; Leite-Morris KA; Gessa GL; Colombo G
    Psychopharmacology (Berl); 2015 May; 232(10):1831-41. PubMed ID: 25420609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA
    Logge WB; Morley KC; Haber PS
    Curr Top Behav Neurosci; 2022; 52():195-212. PubMed ID: 33580440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is R(+)-Baclofen the best option for the future of Baclofen in alcohol dependence pharmacotherapy? Insights from the preclinical side.
    Echeverry-Alzate V; Jeanblanc J; Sauton P; Bloch V; Labat L; Soichot M; Vorspan F; Naassila M
    Addict Biol; 2021 Mar; 26(2):e12892. PubMed ID: 32146727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GABA
    Haile CN; Carper BA; Nolen TL; Kosten TA
    Psychopharmacology (Berl); 2021 Sep; 238(9):2587-2600. PubMed ID: 34228136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
    Slattery DA; Markou A; Froestl W; Cryan JF
    Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
    Addolorato G; Leggio L
    Curr Pharm Des; 2010; 16(19):2113-7. PubMed ID: 20482507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen for the treatment of alcohol dependence.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):11-4. PubMed ID: 22998536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.